Cardiac natriuretic hormones, neuro-hormones, thyroid hormones and cytokines in normal subjects and patients with heart failure

被引:87
作者
Emdin, M [1 ]
Passino, C [1 ]
Prontera, C [1 ]
Iervasi, A [1 ]
Ripoli, A [1 ]
Masini, S [1 ]
Zucchelli, GC [1 ]
Clerico, A [1 ]
机构
[1] CNR, Inst Clin Physiol, Lab Cardiovasc Endocrinol & Cell Biol, I-56126 Pisa, Italy
关键词
brain natriuretic peptide (BNP); cytokines; heart failure; neuro-hormones; thyroid hormones;
D O I
10.1515/CCLM.2004.108
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
The derangement of neuro-endocrine control of circulation influences both disease evolution and response to treatment in patients with heart failure, but little data are available about the complex relationships between the degree of neuro-hormonal activation and clinical severity. We studied the relationships between cardiac natriuretic hormones (CNHs) and several neuro-hormones and immunological markers in a prospective cohort of 105 consecutive patients with cardiomyopathy (77 men and 28 women, mean age 66.7 +/- 12.4 years, range 33-89 years). We assayed the circulating levels of CNHs (atrial natriuretic peptide (ANP) and brain natriuretic peptide (BNP)), plasma renin activity (PRA), aldosterone, cortisol, adrenaline, noradrenaline, thyroid hormones and thyroid stimulating hormone (TSH), tumour necrosis factor-alpha (TNF-alpha) and interleukin-6 (IL-6). The concentrations of all CNHs and neurohormones were higher in patients with heart failure compared to normal subjects, except for free triiodothyronine (FT3), which was below normal values. ANP was positively related to NYHA class, IL-6, adrenaline, noradrenaline and cortisol, while negatively with ejection fraction and FT3. BNP was positively related to age, NYHA class, IL-6, TNF-alpha, adrenaline, noradrenaline and cortisol, while negatively with ejection fraction and FT3. A stepwise multiple linear regression indicated that plasma ANP depended only on ejection fraction, adrenaline and noradrenaline values, while for plasma BNP variation NYHA class contributed too. Our data confirm a progressive activation of hormonal and immunological systems in patients with heart failure. Furthermore, CNH circulating levels in heart failure are affected not only by cardiac function and disease severity, but also by activation of neuro-hormonal and stress-related cytokine systems, as well as by the thyroid hormones, even on usual medical treatment.
引用
收藏
页码:627 / 636
页数:10
相关论文
共 55 条
[21]  
de Bold AJ, 2000, HDB PHYSL 7, V3, P377
[22]   Mechanical and neuroendocrine regulation of the endocrine heart [J].
deBold, AJ ;
Bruneau, BG ;
deBold, MLK .
CARDIOVASCULAR RESEARCH, 1996, 31 (01) :7-18
[23]   ALTERED THYROID-HORMONE METABOLISM IN ADVANCED HEART-FAILURE [J].
HAMILTON, MA ;
STEVENSON, LW ;
LUU, M ;
WALDEN, JA .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1990, 16 (01) :91-95
[24]   Effect of beta-blocker on left ventricular function and natriuretic peptides in patients with chronic heart failure treated with angiotensin-converting enzyme inhibitor [J].
Hara, Y ;
Hamada, M ;
Shigematsu, Y ;
Suzuki, M ;
Kodama, K ;
Kuwahara, T ;
Hashida, H ;
Ikeda, S ;
Ohtsuka, T ;
Hiasa, G ;
Hiwada, K .
JAPANESE CIRCULATION JOURNAL-ENGLISH EDITION, 2000, 64 (05) :365-369
[25]   ALTERED TISSUE DEGRADATION AND DISTRIBUTION OF ATRIAL-NATRIURETIC-PEPTIDE IN PATIENTS WITH IDIOPATHIC DILATED CARDIOMYOPATHY AND ITS RELATIONSHIP WITH CLINICAL SEVERITY OF THE DISEASE AND SODIUM HANDLING [J].
IERVASI, G ;
CLERICO, A ;
BERTI, S ;
PILO, A ;
BIAGINI, A ;
BIANCHI, R ;
DONATO, L .
CIRCULATION, 1995, 91 (07) :2018-2027
[26]   Neurohormonal activation rapidly decreases after intravenous therapy with diuretics and vasodilators for class IV heart failure [J].
Johnson, W ;
Omland, T ;
Hall, C ;
Lucas, C ;
Myking, OL ;
Collins, C ;
Pfeffer, M ;
Rouleau, JL ;
Stevenson, LW .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2002, 39 (10) :1623-1629
[27]  
Kiemer AK, 2001, ANN RHEUM DIS, V60, pIII68
[28]   Mechanisms of disease: Thyroid hormone and the cardiovascular system. [J].
Klein, I ;
Ojamaa, K .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (07) :501-509
[29]   STIMULATION OF BRAIN NATRIURETIC PEPTIDE RELEASE FROM THE HEART BY THYROID-HORMONE [J].
KOHNO, M ;
HORIO, T ;
YASUNARI, K ;
YOKOKAWA, K ;
IKEDA, M ;
KURIHARA, N ;
NISHIZAWA, Y ;
MORII, H ;
TAKEDA, T .
METABOLISM-CLINICAL AND EXPERIMENTAL, 1993, 42 (08) :1059-1064
[30]   Effects of valsartan on circulating brain natriuretic peptide and norepinephrine in symptomatic chronic heart failure - The Valsartan Heart Failure Trial (Val-HeFT) [J].
Latini, R ;
Masson, S ;
Arland, I ;
Judd, D ;
Maggioni, AP ;
Chiang, YT ;
Bevilacqua, M ;
Salio, M ;
Cardano, P ;
Dunselman, PHJM ;
Holwerda, NJ ;
Tognoni, G ;
Cohn, JN .
CIRCULATION, 2002, 106 (19) :2454-2458